A client is prescribed sertraline, a selective serotonin reuptake inhibitor, for the treatment of depression. The nurse understands that the therapeutic effect of this medication is achieved through which pharmacologic action?

A. Increasing the release of dopamine and norepinephrine in the brain: Sertraline primarily affects serotonin, not dopamine or norepinephrine. Increasing dopamine or norepinephrine release is the mechanism of action for other antidepressants, such as certain SNRIs or bupropion. B. Blocking the reuptake of serotonin and increasing availability in the brain: Sertraline inhibits the reabsorption of serotonin into presynaptic neurons, increasing its concentration in the synaptic cleft. This enhances serotonergic neurotransmission, which contributes to improved mood and reduction of depressive symptoms over time. C. Blocking acetylcholine receptors to reduce anxiety and elevate mood: Anticholinergic effects are not the mechanism by which sertraline works. Blocking acetylcholine receptors may cause side effects like dry mouth or constipation but does not produce the antidepressant effect. D. Decreasing serotonin production in the brain to prevent overstimulation: Sertraline does not decrease serotonin production. Reducing serotonin levels would worsen depressive symptoms rather than treat them. Its therapeutic action relies on increasing serotonin availability.